Nagler; Arnon

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nagler; Arnon.The latest application filed is for "composition and method for treating or preventing skeletal muscle fibrosis".

Company Profile

0.13.17

Nagler; Arnon - Jerusalem IL
Nagler; Arnon - Jerusalam IL
Nagler; Arnon - 74381 Jerusalem IL
Nagler; Arnon - Palo Alto CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Composition And Method For Treating Or Preventing Skeletal Muscle Fibrosis App 20170151242 - Pines; Mark ; et al.	2017-06-01
Composition And Method For Treating Or Preventing Skeletal Muscle Fibrosis App 20160030429 - Pines; Mark ; et al.	2016-02-04
Composition and method for treating or preventing skeletal muscle fibrosis Grant 9,023,859 - Pines , et al. May 5, 2	2015-05-05
Composition And Method For Treating Or Preventing Skeletal Muscle Fibrosis App 20130281472 - Pines; Mark ; et al.	2013-10-24
Composition and method for treating or preventing skeletal muscle fibrosis Grant 8,410,120 - Pines , et al. April 2, 2	2013-04-02
Composition And Method For Treating Or Preventing Skeletal Muscle Fibrosis App 20100144766 - Pines; Mark ; et al.	2010-06-10
Method For Selectively Expanding, Selecting And Enriching Stem/Progenitor Cell Populations App 20090298045 - Treves; Avraham J. ; et al.	2009-12-03
Compositions of Cells Enriched for Combinations of Various Stem and Progenitor Cell Populations, Methods of Use Thereof and Methods of Private Banking Thereof App 20080226612 - Treves; Avraham ; et al.	2008-09-18
Quinazolinone containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies Grant RE39,574 - Pines , et al. April 17, 2	2007-04-17
Inhibition of pathogenic processes related to tissue trauma App 20070010538 - Pines; Mark ; et al.	2007-01-11
Promotion of wound healing App 20060293351 - Pines; Mark ; et al.	2006-12-28
Quinazolinone compositions for regulation of gene expression related to pathological processes App 20060258692 - Pines; Mark ; et al.	2006-11-16
Methods and kits for diagnosing and monitoring hematopoietic cancers App 20060223108 - Pecker; Iris ; et al.	2006-10-05
Treatment for renal fibrosis App 20060194822 - Nagler; Arnon ; et al.	2006-08-31
Treatment of skin disorders Grant RE39,096 - Pines , et al. May 16, 2	2006-05-16
Quinazolinone compounds in combined modalities for improved cancer treatment App 20060009475 - Pines; Mark ; et al.	2006-01-12
Treatment of renal fibrosis App 20040171627 - Nagler, Arnon ; et al.	2004-09-02
Treatment of hepatic cirrhosis App 20040039003 - Pines, Mark ; et al.	2004-02-26
Methods and kits for diagnosing and monitoring hematopoietic cancers App 20030148321 - Pecker, Iris ; et al.	2003-08-07
Treatment of hepatic cirrhosis Grant 6,562,829 - Pines , et al. May 13, 2	2003-05-13
Intracoronary stents containing quinazolinone derivatives Grant 6,159,488 - Nagler , et al. December 12, 2	2000-12-12
Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization Grant 6,090,814 - Nagler , et al. July 18, 2	2000-07-18
Quinazolinone containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies Grant 6,028,075 - Pines , et al. February 22, 2	2000-02-22
Treatment and prevention of adhesions Grant 5,852,024 - Pines , et al. December 22, 1	1998-12-22
Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof Grant 5,449,678 - Pines , et al. September 12, 1	1995-09-12
Method of purging residual tumor cells in vitro with lymphokine activated cytotoxic cells Grant 5,041,289 - Phillips , et al. August 20, 1	1991-08-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.